Universitaetsklinikum Augsburg

At Universitaetsklinikum Augsburg, a major share of research in oncology and hematology focuses on cancers of the blood and lymphatic system, including acute myeloid leukemia, acute lymphoblastic leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes. These studies are designed to test new treatment approaches, improve outcomes after standard therapy, and refine strategies for difficult-to-treat or relapsed disease.

• Blood cancers such as AML, ALL, NHL, and myeloma
• Transplantation and post-transplant treatment optimization
• Evaluating targeted, immune-based, and combination therapies

The site’s work in this area also includes research on graft-versus-host disease and treatment support after stem cell transplantation, reflecting a strong focus on both disease control and long-term patient care.

Research on solid tumors at the II. Medizinische Klinik covers a wide range of diseases, including breast cancer, lung cancer, colorectal cancer, prostate cancer, gastric cancer, biliary tract cancer, and melanoma. Many trials aim to improve survival, reduce recurrence, and match treatment more closely to tumor biology.

• Breast cancer, including HER2-positive and triple-negative disease
• Lung cancer and other advanced thoracic malignancies
• Prostate, colorectal, and gastrointestinal cancers

A key theme is precision oncology, with studies exploring biomarker-guided therapy, targeted approaches, and combinations intended to improve response in advanced or high-risk disease.

The site conducts important studies in neuro-oncology and pediatric oncology, including research on glioblastoma, medulloblastoma, ependymoma, and low-grade glioma, as well as childhood blood cancers and rare solid tumors. These trials are aimed at improving disease control, supporting safer treatment in children, and addressing tumors with specific genetic features.

• Brain tumors in adults and children
• Pediatric leukemia and lymphoma
• Genetically defined tumors requiring tailored treatment

This research reflects a strong commitment to developing better therapies for young patients with aggressive or rare cancers, while also evaluating how to make treatment more effective and tolerable.

Clinical trials at Universitaetsklinikum Augsburg also address immune system diseases and chronic inflammatory conditions such as systemic lupus erythematosus, systemic sclerosis, Crohn’s disease, ulcerative colitis, psoriasis, and hidradenitis suppurativa. The overall goal is to test new therapies that may better control symptoms, reduce flares, and improve daily functioning.

• Autoimmune diseases and immune-mediated inflammation
• Inflammatory bowel disease such as Crohn’s disease and ulcerative colitis
• Skin and connective tissue disorders including psoriasis

The research portfolio in this area includes both symptom-focused studies and trials designed to improve long-term disease control in patients with persistent immune-related conditions.

A substantial part of the research portfolio involves skin diseases and allergic disorders, including atopic dermatitis, urticaria, prurigo nodularis, actinic keratosis, and allergic rhinoconjunctivitis. These trials are generally focused on testing new treatments, easing symptoms, and preventing disease worsening.

• Atopic dermatitis and other chronic itchy skin conditions
• Allergic rhinitis and pollen-induced eye and nose symptoms
• Precancerous and inflammatory skin lesions

The dermatology and allergy studies at Universitaetsklinikum Augsburg aim to improve comfort, reduce flare frequency, and support better long-term management for both children and adults.

Research in cardiovascular disease and critical care includes studies in aortic stenosis, atrial fibrillation, stroke, severe infection, and intensive care settings. These trials often aim to improve recovery, reduce complications, and support better decision-making in acutely ill patients.

• Heart and vascular disease, including valve and rhythm disorders
• Stroke and other acute neurological emergencies
• ICU and severe infection management

The site’s hospital-based research also includes studies of supportive interventions designed to improve outcomes after surgery or during serious illness.

The clinical trial program includes digestive system diseases and nutritional and metabolic disorders such as Crohn’s disease, ulcerative colitis, gastroparesis, type 1 diabetes, and metabolic acidosis. These studies are intended to improve symptom control, disease stability, and treatment effectiveness in chronic conditions.

• Inflammatory bowel disease and related gastrointestinal disorders
• Diabetes and other metabolic conditions
• Functional digestive disorders affecting nutrition and quality of life

This area highlights a practical focus on long-term disease management, with trials that seek better control of persistent symptoms and fewer complications.

Trials in infectious diseases and respiratory medicine address conditions such as COVID-19, viral lung infections, bacteremia, and pneumonia, along with other severe hospital infections. The main purpose is to evaluate treatments that may improve recovery and lower the risk of serious complications.

• Viral and bacterial infections
• Severe respiratory illness in hospitalized patients
• Infection-related outcomes in critical care settings

These studies support the site’s broader role in managing complex inpatient conditions where rapid and effective treatment can make a major difference.